DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | US

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Ulisse Biomed Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.	Italy	UBM
UTAH MEDICAL PRODUCTS INC Develops specialty medical devices to improve healthcare outcomes for women and their babies.	United States of America	UTMD
UXN Co., Ltd. Develops advanced continuous glucose monitoring systems and sensors for diabetes management.	South Korea	337840
Venus Concept Inc. Develops aesthetic & hair restoration systems for professionals on a subscription model.	United States of America	VERO
Viromed Medical Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.	Germany	VMED
Vitrolife A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.	Sweden	VITR
Vitruvia Medical AG Circular economy provider for robotic surgery instruments for European clinics and hospitals.	Germany	991
Vivos Therapeutics, Inc. Develops non-surgical oral appliance technology to treat the root causes of sleep apnea.	United States of America	VVOS
Vyome Holdings, Inc Develops therapies for inflammatory diseases and medical devices for obesity management.	United States of America	HIND
WEST PHARMACEUTICAL SERVICES INC Global manufacturer of containment and delivery systems for injectable drugs.	United States of America	WST